Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders

Chronic administration of the atypical antipsychotic drug, clozapine, to rodents has been shown to increase the concentration of apolipoprotein D (apoD) in several area of the brain, suggesting that apoD could be involved in the therapeutic effects of antipsychotic drugs and/or the pathology of psychotic illnesses. Here, we measured a significant decrease in the concentration of apoD in serum samples from schizophrenic patients. In contrast, apoD levels were significantly increased (92–287%) in dorsolateral prefrontal cortex (Brodmann's area 9) of schizophrenic and bipolar subjects. Elevated levels of apoD expression were also observed in the caudate of schizophrenic and bipolar subjects (68–89%). No differences in apoD immunoreactivity were detected in occipital cortex (Brodmann's area 18) in either group, or in the hippocampus, substantia nigra, or cerebellum of the schizophrenic group. The low serum concentrations of apoD observed in these patients supports recent hypotheses involving systemic insufficiencies in lipid metabolism/signaling in schizophrenia. Elevation of apoD expression selectively within central nervous system regions implicated in the pathology of these neuropsychiatric disorders suggests a focal compensatory response that neuroleptic drug regimens may augment.

Comorbidity of Major Depressive Disorder and Somatization Disorder: Base Rates in an Outpatient Psychiatric Sample.

Somatization Disorder is a rare psychological condition that affects approximately 2% of women and 0.2% of men in the United States. This archival study was undertaken to develop base rates for the prevalence of Major Depressive Disorder among a group of outpatients previously diagnosed with Somatization Disorder in a community mental health clinic. The Shedler Quick PsychoDiagnostics Panel (QPD Panel) was utilized to sort patients into a Somatization Disorder and control group. A 2 x 2 Pearson's Chi-Square Test of Independence was utilized. In this study, 44% of patients who were identified as having Somatization Disorder were also diagnosed with Major Depressive Disorder. The implications for these results are discussed herein.

Anxiety and depression symptoms in liver encephalopathy : are they psychiatric or organic?

Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2014

Mohave ethnopsychiatry and suicide: the psychiatric knowledge and the psychic disturbances of an Indian tribe.

Bibliography: p. 553-567.